Topic: biomedical research
WuXi AppTec’s CRO arm WuXi Clinical will subsume Pharmapace into its business as the China giant looks to up its trial services in biometrics.
With sites around the U.S. and increasingly around the world, J&J's startup arm JLABS has opened its latest hub in Washington, D.C.
Merck is set to cut 20 staffers from its Research Laboratories unit as it prepares to enter its new digs in South San Francisco.
AstraZeneca has signed on to be a founding partner for a new life sciences research hub in China, to be housed just west of Shanghai.
Trump’s budget proposals for 2020 are in, seeking a cut for the NIH for the third year in a row but an increase in the FDA’s finances.
Microsoft is bringing its coding skills to bear on biotech, with the goal of building a platform for programming the biology of living cells.
Amicus plans to build an R&D center in the heart of Philadelphia’s University City, not long after inking a $100 million deal for 10 gene therapies.
Charles River has added another string to its early-stage R&D bow by acquiring preclinical services firm Citoxlab for $510 million in cash.
Johnson & Johnson Innovation joined a medical device incubator backed by Deerfield while making an investment of its own through J&J’s venture arm.
Join as Diane Hayes, PHD, InCrowd President and Co-founder, reviews the results from the 2019 physician predictions survey and considers the year ahead.